August 17, 2009 - Elekta has received a multiple order of six radiation therapy systems from the Cancer Institute of the State of São Paulo. The order encompasses two Elekta Synergy Platform, three Elekta Synergy and one Elekta Axesse. Elekta will make the institute its training and product development center in Latin America.

The Cancer Institute of the State of São Paulo, ICESP, is a social organization of Health, created by the State Government in partnership with the Foundation School of Medicine to be the largest hospital specializing in the treatment of cancer in Latin America.

By winning this public tender, Elekta will make the institute its training and product development center in Latin America with the entire product portfolio available including hardware, software, planning system, management system and linear accelerators. The institute will be equipped with two Elekta Synergy Platform, three Elekta Synergy, one Elekta Axesse, 30 MOSAIQ stations and 19 CMS treatment planning systems.

About 6,000 patients diagnosed with cancer are treated at the institute every month, and attended by some of Brazil's most qualified professionals in this specialty. A key feature of the institute is the innovation in assistance, which allows the patient to have all phases of his care, diagnosis and rehabilitation, integrated in the same place.

Besides medical care, the professionals of ICESP develop teaching and research activities in accordance with the medical model of education introduced by the University of São Paulo Medicine - USP. The goal is to transform the institute into a research center of international reference in the area of cancer, including the study of new drugs and innovative treatments for the disease.

Elekta started its own subsidiary in São Paulo in the beginning of 2008, an investment, which has been a success. The Latin American market has successfully proved to be a growth market for Elekta.

Elekta Synergy Platform is a unique linear accelerator that is X-ray volume imaging (XVI) - ready. Based on the IMRT technology developed by Elekta, modifications have been undertaken in order to maintain isocenter accuracy and stability while incorporating the facility to add the additional weight of imaging, detector and robotic technology into the drum design of the treatment machine at a later stage.

Elekta Synergy, the first advanced multi-functional linear accelerator with intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT), enables clinicians to both image and treat patients in the same frame of reference, at the time of treatment. The result is unmatched clinical confidence, enabling more aggressive treatment of tumors while minimizing damage to surrounding healthy tissue.

Elekta Axesse is a fully integrated stereotactic system that combines true three-dimensional (3D) image guidance at the time of treatment with highly conformal beam shaping and robotic 6D sub-millimeter patient positioning to deliver fast, efficient and accurate treatment.

MOSAIQ is an image-enabled oncology electronic medical record (EMR) with fully integrated business features such as scheduling, billing and management reporting and analysis.

For more information: www.elekta.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now